Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Topiramate Stories

2012-10-11 04:03:56

The Consumer Justice Foundation, a for-profit corporation whose team of professional consumer advocates provides continuous updates regarding free online information relating to the potential dangers of using certain prescription medications, has a Web site URL that is located at http://www.topamaxbirthinjury.com. The CJF hereby reports that a study published by researchers in Taiwan concluded that the use of acupuncture by people suffering from migraine headaches reduced the episodes of...

2012-10-08 07:23:46

MOUNTAIN VIEW, Calif., Oct. 8, 2012 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that Express Scripts, the country's largest Pharmacy Benefit Manager (PBM), has joined the Qsymia Certified Home Delivery Pharmacy Network. Qsymia is available only through mail order from the Qsymia Certified Home Delivery Pharmacy Network, including CVS Pharmacy, Walgreens and now Express Scripts, as part of the Qsymia Risk Evaluation and Mitigation Strategy (REMS) program. Contact information...

2012-09-20 02:28:11

MOUNTAIN VIEW, Calif., Sept. 20, 2012 /PRNewswire/ -- VIVUS, Inc. (Nasdaq:VVUS) today announced that multiple scientific abstracts will be presented at Obesity 2012, the 30th Annual Scientific Meeting of The Obesity Society, to be held September 20(th) to September 24(th) in San Antonio, Texas. The Obesity Society's Annual Scientific Meeting has grown to be one of the largest gatherings of obesity professionals worldwide. The posters will be displayed in Exhibit Hall C of the Henry B....

2012-09-18 02:26:55

MOUNTAIN VIEW, Calif., Sept. 18, 2012 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced the U.S. market availability of Qsymia(TM) (pronounced Kyoo sim ee' uh). Qsymia is FDA-approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese), or 27 or greater (overweight) in the presence of at least one weight-related comorbidity, such as hypertension, type 2...

2012-09-05 23:03:14

The Food and Drug Administration recently approved a new weight loss drug called Qsymia, its first weight loss drug approval in 13 years. Qsymia's own clinical studies show this weight loss pill only sheds a mere 10% of body weight per year or for a 200 pound person, a shy 20 pounds in one year. Diet Doc hCG Diet in-house study shows patients lose an average of 30 pounds per month. Dallas, TX (PRWEB) September 04, 2012 Diet Doc hCG Diet in-house study shows that patients lose an average of...

2012-08-10 23:00:13

On July 17th, 2012, the US FDA approved the new diet pill Qsymia by Vivus Inc. Qsymia is a combination of two FDA-approved drugs, phentermine and topiramate, in an extended-release formulation. Phentermine was one-half of the popular Wyeth obesity drug Fen Phen which was withdrawn from the market in 1997; it was linked with heart valve damage and primary pulmonary hypertension (PPH). Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions...

2012-07-18 18:20:40

TAINAN, Taiwan, July 18, 2012 /PRNewswire-Asia/ -- ScinoPharm (TWSE:1789) announced today that its Tainan, Taiwan Facility will provide commercial manufacturing of topiramate active pharmaceutical ingredient ("API") for VIVUS' Qsymia(TM), a new drug for the treatment of obesity approved by the United States Food and Drug Administration on July 17, 2012. Qsymia(TM) is the first FDA-approved once daily combination treatment for chronic weight management in adults who are obese or...

Qsymia: Third Weight-Loss Drug Approved BY FDA In Thirteen Years
2012-07-18 13:04:53

Lawrence LeBlond for redOrbit.com - Your Universe Online The second new weight-management drug in 13 years has been approved by US regulators for use in people who are obese or overweight and have certain medical conditions. The drug, Qsymia, developed by pharmaceutical company Vivus, received Food and Drug Administration (FDA) approval just a month after another anti-obesity drug, called Belviq, was given a thumbs up. Qsymia has been approved for use in obese adults with a body mass...

2012-07-17 14:21:16

MOUNTAIN VIEW, Calif., July 17, 2012 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that the U.S. Food and Drug Administration (FDA) has approved Qsymia(TM) (pronounced Kyoo sim ee' uh) as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese), or 27 or greater (overweight) in the presence of at least one weight-related comorbidity, such as hypertension,...

2012-06-25 23:25:24

An experimental drug helped significantly more overweight patients with diabetes shed pounds, compared with placebo, a new study finds. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston. "This new medication is promising because of the amount of weight loss it produces, the resultant improvement in important risk factors for diabetes, and, particularly in the lower dose studied, in its tolerability," said study lead author Donna H. Ryan, M.D.,...